Surgery Partners Inc. (SGRY) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Surgery Partners Inc. (SGRY) slipped -0.13% to $23.21 as options desks priced 56% call premium vs. 44% put protection around the $23 max-pain magnet. Solid 41% profit margin (10% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during m
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
UBS analyst A.J. Rice downgrades Surgery Partners (NASDAQ:SGRY) from Buy to Neutral and raises the price target from $21 to $23.5.
HealthSpan, the investment arm of Bon Secours, wants to take Surgery Partners private and absorb its 30-state outpatient footprint.
Surgery Partners (SGRY) is at the center of a going private deal after HealthSpan Partners agreed to acquire a 61.24% stake in an all cash transaction valued at about US$5.7b. The HealthSpan offer has sharply reset expec
StoneX analyst Bill Sutherland downgrades Surgery Partners (NASDAQ:SGRY) from Buy to Hold.
Surgery Partners has jumped sharply in recent weeks, and with a buyout now agreed, the key issue for readers is whether the current price can be backed up by the cash the business is expected to generate over time. With
Surgery Partners Inc. (NASDAQ:SGRY) saw its share price soar by 47.62 percent on Monday to close at $23.25 apiece after agreeing to be acquired by HealthSpan Partners for a total of $5.7 billion. In a joint statement on
Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 46.4% in the afternoon session after HealthSpan Partners, an affiliate of Bon Secours Mercy Health, agreed to acquire the company in an all-cash transact
On Oct. 26, 2026, Anthropic's IPO filing sparked a tech rally, while Meta's $95 billion AI infrastructure plan weighed on sentiment.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on SGRY today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for SGRY. Explore sector supply chains on /butterfly.
Why SGRY Stock slipped -0.13% Today — RQD Quant Desk Flash. Solid 41% profit margin (10% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.